| International Mexiletine and Placebo Antiarrhythmic Coronary Trial (IMPACT): II. Results from 24-hour electrocardiograms. IMPACT Research Group. | |
| | |
MedLine Citation:
|
PMID: 3533546 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The sustained release form of mexiletine (Mexitil-Perlongets), 360 mg b.i.d., was evaluated for antiarrhythmic efficacy in a double-blind placebo trial in 630 patients with recent documented myocardial infarction. The drug was effective in reducing the occurrence of complex forms of ventricular arrhythmias as well as frequent premature ventricular complexes during the first four months of treatment. In addition, a favourable trend in antiarrhythmic efficacy of the drug was observed after 12 months of treatment, but this was not statistically significant. The data from this study suggest that mexiletine was as effective in preventing the occurrence of frequent or complex cardiac arrhythmias as in reducing such arrhythmias present during the first four months following acute myocardial infarction. Mortality was higher in the mexiletine group (7.6%) than in the placebo group (4.8%), although the difference was not statistically significant. |
| | |
Authors:
|
- |
Related Documents
:
|
1739956 - Tachycardias of right ventricular origin. 22163536 - Myocardial motion analysis for determination of tei-index of human heart. 1869496 - Is doxepin a safer tricyclic for the heart? 20155856 - Cardiac arrhythmia management using a noncontact mapping multielectrode array. 18084986 - Perioperative complications in patients with drug-eluting stents: a three-year audit at... 22215856 - Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran... |
Publication Detail:
|
Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: European heart journal Volume: 7 ISSN: 0195-668X ISO Abbreviation: Eur. Heart J. Publication Date: 1986 Sep |
Date Detail:
|
Created Date: 1986-12-05 Completed Date: 1986-12-05 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8006263 Medline TA: Eur Heart J Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 749-59 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Arrhythmias, Cardiac / drug therapy*, mortality Clinical Trials as Topic Double-Blind Method Electrocardiography Female Heart Ventricles Humans Male Mexiletine / blood, therapeutic use* Middle Aged Myocardial Infarction / complications Time Factors |
| Chemical | |
Reg. No./Substance:
|
31828-71-4/Mexiletine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Role of programmed electrical stimulation of the heart in the selection and design of implantable un...
Next Document: Cardiovascular reactivity to mental stress during gradual withdrawal of chronic postinfarction treat...